BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26824212)

  • 21. The bone conduction implant: Clinical results of the first six patients.
    Reinfeldt S; Håkansson B; Taghavi H; Fredén Jansson KJ; Eeg-Olofsson M
    Int J Audiol; 2015 Jun; 54(6):408-16. PubMed ID: 25705995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy and precision of direct bone conduction measurements.
    Sadeghi AM; Flynn M; Davison T; Schulte M; Hillbratt M
    B-ENT; 2016; 12(1):41-51. PubMed ID: 27097393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary functional results and quality of life after implantation of a new bone conduction hearing device in patients with conductive and mixed hearing loss.
    Ihler F; Volbers L; Blum J; Matthias C; Canis M
    Otol Neurotol; 2014 Feb; 35(2):211-5. PubMed ID: 24448279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcutaneous bone-conduction hearing device: audiological and surgical aspects in a first series of patients with mixed hearing loss.
    Barbara M; Perotti M; Gioia B; Volpini L; Monini S
    Acta Otolaryngol; 2013 Oct; 133(10):1058-64. PubMed ID: 23768011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcutaneous bone conductive implants in patients with conductive/mixed hearing loss: audiological outcomes in noise condition.
    Magliulo G; Iannella G; De Vincentiis M; Turchetta R; Portanova G; Angeletti D; Mancini P
    Acta Otolaryngol; 2018 Sep; 138(9):822-829. PubMed ID: 29939073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-Year Follow-Up with the Bone Conduction Implant.
    Persson AC; Reinfeldt S; Håkansson B; Rigato C; Fredén Jansson KJ; Eeg-Olofsson M
    Audiol Neurootol; 2020; 25(5):263-275. PubMed ID: 32268333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Audiological and subjective benefit results in bone-anchored hearing device users.
    Boleas-Aguirre MS; Bulnes Plano MD; de Erenchun Lasa IR; Ibáñez Beroiz B
    Otol Neurotol; 2012 Jun; 33(4):494-503. PubMed ID: 22472615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comparative Study of a Novel Adhesive Bone Conduction Device and Conventional Treatment Options for Conductive Hearing Loss.
    Skarzynski PH; Ratuszniak A; Osinska K; Koziel M; Krol B; Cywka KB; Skarzynski H
    Otol Neurotol; 2019 Aug; 40(7):858-864. PubMed ID: 31295197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Objective and subjective results of the Bonebridge transcutaneous active direct-drive bone conduction hearing implant.
    Alzhrani F
    Saudi Med J; 2019 Aug; 40(8):797-801. PubMed ID: 31423516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective Analysis of Hearing-Impaired Adult Patients Treated With an Active Transcutaneous Bone Conduction Implant.
    Rader T; Stöver T; Lenarz T; Maier H; Zahnert T; Beleites T; Hagen R; Mlynski R; Baumgartner WD
    Otol Neurotol; 2018 Aug; 39(7):874-881. PubMed ID: 29847467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Horizontal sound localisation accuracy in individuals with conductive hearing loss: effect of the bone conduction implant.
    Asp F; Reinfeldt S
    Int J Audiol; 2018 Sep; 57(9):657-664. PubMed ID: 29764239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Speech understanding in quiet and in noise with the bone-anchored hearing aids Baha Compact and Baha Divino.
    Kompis M; Krebs M; Häusler R
    Acta Otolaryngol; 2007 Aug; 127(8):829-35. PubMed ID: 17762993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hearing performance with 2 different high-power sound processors for osseointegrated auditory implants.
    Kurz A; Caversaccio M; Kompis M
    Otol Neurotol; 2013 Jun; 34(4):604-10. PubMed ID: 23652327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Use of a Novel, Nonsurgical Bone Conduction Hearing Aid System for the Treatment of Conductive Hearing Loss.
    Kuthubutheen J; Broadbent C; Marino R; Távora-Vieira D
    Otol Neurotol; 2020 Aug; 41(7):948-955. PubMed ID: 32282787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A New Transcutaneous Bone Conduction Hearing Implant: Short-term Safety and Efficacy in Children.
    Baumgartner WD; Hamzavi JS; Böheim K; Wolf-Magele A; Schlögel M; Riechelmann H; Zorowka P; Koci V; Keck T; Potzinger P; Sprinzl G
    Otol Neurotol; 2016 Jul; 37(6):713-20. PubMed ID: 27153327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcutaneous Baha Attract system: Long-term outcomes of the French multicenter study.
    Nevoux J; Coudert C; Boulet M; Czajka C; Tavernier L; Daval M; Ayache D; Meller R; Rossetto S; Papon JF; Deveze A
    Clin Otolaryngol; 2018 Dec; 43(6):1553-1559. PubMed ID: 30137669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Bonebridge in Adults with Mixed and Conductive Hearing Loss: Audiological and Quality of Life Outcomes.
    Skarżyński PH; Ratuszniak A; Król B; Kozieł M; Osińska K; Cywka KB; Sztabnicka A; Skarżyński H
    Audiol Neurootol; 2019; 24(2):90-99. PubMed ID: 31141814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Auditory Performance and Subjective Satisfaction with the ADHEAR System.
    Almuhawas F; Alzhrani F; Saleh S; Alsanosi A; Yousef M
    Audiol Neurootol; 2021; 26(1):1-10. PubMed ID: 32544908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Baha system in patients with single-sided deafness and contralateral hearing loss.
    Wazen JJ; Van Ess MJ; Alameda J; Ortega C; Modisett M; Pinsky K
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):554-9. PubMed ID: 20304277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia®.
    Rauch AK; Wesarg T; Aschendorff A; Speck I; Arndt S
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4279-4288. PubMed ID: 34792628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.